GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IDT Australia Ltd (ASX:IDT) » Definitions » EPS (Diluted)

IDT Australia (ASX:IDT) EPS (Diluted) : A$-0.01 (TTM As of Dec. 2024)


View and export this data going back to 1991. Start your Free Trial

What is IDT Australia EPS (Diluted)?

IDT Australia's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was A$-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.01.

IDT Australia's EPS (Basic) for the six months ended in Dec. 2024 was A$-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.01.

IDT Australia's EPS without NRI for the six months ended in Dec. 2024 was A$-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


IDT Australia EPS (Diluted) Historical Data

The historical data trend for IDT Australia's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDT Australia EPS (Diluted) Chart

IDT Australia Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 0.01 -0.01 -0.03 -0.02

IDT Australia Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.01 -0.01 -0.01 -0.01

Competitive Comparison of IDT Australia's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDT Australia's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IDT Australia's PE Ratio distribution charts can be found below:

* The bar in red indicates where IDT Australia's PE Ratio falls into.


;
;

IDT Australia EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

IDT Australia's Diluted EPS for the fiscal year that ended in Jun. 2024 is calculated as

Diluted EPS (A: Jun. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-5.413-0)/348.222
=-0.02

IDT Australia's Diluted EPS for the quarter that ended in Dec. 2024 is calculated as

Diluted EPS (Q: Dec. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.251-0)/425.081
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IDT Australia  (ASX:IDT) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


IDT Australia EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of IDT Australia's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


IDT Australia Business Description

Traded in Other Exchanges
N/A
Address
45 Wadhurst Drive, Boronia, Melbourne, VIC, AUS, 3155
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.